| abstract |
Use of compounds of the formulan n wherein n R1 and R2 are each independently hydrogen, methyl-, ethyl, propyl-, butyl, or R1 and R2 are together cycloalkyl; n R3 is methoxy, ethoxy, hydroxy, hydrogen, C1-C4 Alkyl, halogen; n n=1,2 or 3, nor any pharmaceutically acceptable salts thereof, for the preparation of neuroprotective pharmaceutical compositions, for the prevention or treatment of glutamate-induced and glutamate receptor mediated neurotoxicity and functional disturbances of the central nervous system. |